1upv
From Proteopedia
Line 1: | Line 1: | ||
- | [[Image:1upv.gif|left|200px]]<br /><applet load="1upv" size=" | + | [[Image:1upv.gif|left|200px]]<br /><applet load="1upv" size="350" color="white" frame="true" align="right" spinBox="true" |
caption="1upv, resolution 2.10Å" /> | caption="1upv, resolution 2.10Å" /> | ||
'''CRYSTAL STRUCTURE OF THE HUMAN LIVER X RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST'''<br /> | '''CRYSTAL STRUCTURE OF THE HUMAN LIVER X RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST'''<br /> | ||
Line 7: | Line 7: | ||
==About this Structure== | ==About this Structure== | ||
- | 1UPV is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with 444 as [http://en.wikipedia.org/wiki/ligand ligand]. Known structural/functional Site: <scene name='pdbsite=AC1:444 Binding Site For Chain A'>AC1</scene>. Full crystallographic information is available from [http:// | + | 1UPV is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=444:'>444</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Known structural/functional Site: <scene name='pdbsite=AC1:444+Binding+Site+For+Chain+A'>AC1</scene>. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1UPV OCA]. |
==Reference== | ==Reference== | ||
Line 25: | Line 25: | ||
[[Category: transcription factor]] | [[Category: transcription factor]] | ||
- | ''Page seeded by [http:// | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Feb 3 10:03:47 2008'' |
Revision as of 08:03, 3 February 2008
|
CRYSTAL STRUCTURE OF THE HUMAN LIVER X RECEPTOR BETA LIGAND BINDING DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST
Overview
LXRbeta belongs to the nuclear hormone receptor superfamily of, ligand-activated transcription factors. Its natural ligands are supposed, to be oxidised derivatives of cholesterol. Stimulation of LXRbeta by, agonists activates a number of genes that are involved in the regulation, of lipid metabolism and cholesterol efflux from cells. Therefore, LXRbeta, may represent a novel therapeutic target for the treatment of dyslipidemia, and atherosclerosis.Here, we report the X-ray crystal structure of the, LXRbeta ligand-binding domain in complex with a synthetic agonist, T-0901317. This compound occupies the ligand-binding pocket of the, receptor, forms numerous lipophilic contacts with the protein and one, crucial hydrogen bond to His435 and stabilises the agonist conformation of, the receptor ligand-binding domain. The recruitment of the AF2-region of, the protein is not achieved via direct polar interactions of the ligand, with protein side-chains of this helical segment, but rather via few, hydrophobic contacts and probably more importantly via indirect effects, involving the pre-orientation of side-chains that surround the, ligand-binding pocket and form the interface to the AF2-helix.On the basis, of these results we propose a binding mode and a mechanism of action for, the putative natural ligands, oxidised derivatives of cholesterol.
About this Structure
1UPV is a Single protein structure of sequence from Homo sapiens with as ligand. Known structural/functional Site: . Full crystallographic information is available from OCA.
Reference
Crystal structure of the human liver X receptor beta ligand-binding domain in complex with a synthetic agonist., Hoerer S, Schmid A, Heckel A, Budzinski RM, Nar H, J Mol Biol. 2003 Dec 12;334(5):853-61. PMID:14643652
Page seeded by OCA on Sun Feb 3 10:03:47 2008